OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0938-AU33         View EO 12866 Meetings	Received Date: 08/10/2020
Title: Clinical Laboratory Improvement Amendments and Patient Protection and Affordable Care Act; Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (CMS-3401)
Agency/Subagency: HHS / CMS	Stage: Interim Final Rule
Concluded Action: Consistent with Change	Concluded Date: 08/26/2020
Legal Deadline: None	Economically Significant: Yes
Publication Date: 09/02/2020	Unfunded Mandates: No
Major: Yes	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses, Organizations
Federalism Implications: Yes	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No